Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_provenance.
- NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_assertion wasGeneratedBy ECO_0000203 NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_provenance.
- NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_assertion wasDerivedFrom befree-2016 NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_provenance.
- NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_assertion SIO_000772 22898604 NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_provenance.
- NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_assertion evidence source_evidence_literature NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_provenance.
- NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_assertion description "[Our studies demonstrate that inhibitors of autophagy or cathepsin B activity and/or molecular targeting of p62/SQSTM1, Atg7, or cathepsin B result in partial reversal of the suppressive effects of AS(2)O(3) on BCR-ABL expressing leukemic progenitors, including primitive leukemic precursors from chronic myelogenous leukemia (CML) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005723.RAG2w1qb-AUwt6Up_vygcPJ5u--a6jFlsyYk5U26UD2Fw130_provenance.